Our mission is to address clients’ needs through innovative products. A substantial share of our revenue is invested in research and development into novel applications of new and existing biomaterials. The goal is to ensure a steady flow of new products to the marketplace.
Our Medical, Marketing, Finance and Strategic Development departments support these research and development programs, and collaborate on global strategies for new products from early stage development and continuing throughout a product's life cycle.

The Research and Development department brings together a multidisciplinary team of leading scientists, innovators and educators developing new product concepts and intellectual property, evaluating outside technology and assisting in the transfer of processes to manufacturing and the regulatory approval process.

Prollenium currently has several major product development projects underway, with other projects pending review and proof-of-concept evaluations.

One strength of Prollenium Medical is getting a drug or device to market in the most efficient and safe manner possible. Our team of scientists and developers in concert with marketing take a systematic and well-defined approach to the development of new products, from initial concept to regulatory approval and market launch. This approach embodies the requirements of design control expected by regulators and culminates in the high-quality products expected by our customers.

Our dedication to research and product development ensures that we will always stay on the cutting edge of the medical aesthetic and therapeutic fields.
Research and development programs